More than 90 people have presented to emergency departments in Illinois and four other states since March 10 with serious unexplained bleeding, including two patients who died, the Centers for Disease Control and Prevention said yesterday in an alert to clinicians. All but five of the cases were in Illinois, including the two deaths, and the rest were in Indiana, Maryland, Missouri and Wisconsin. Laboratory investigation confirmed exposure to brodifacoum, a vitamin K antagonist anticoagulant, in at least 18 of the patients. All 63 patients interviewed by Illinois public health epidemiologists reported using synthetic cannabinoids, and at least three synthetic cannabinoid product samples related to the outbreak have tested positive for brodifacoum, CDC said. Health care providers should screen patients presenting with unexplained bleeding and a possible history of synthetic cannabinoid for vitamin K-dependent antagonist coagulopathy, and report suspected cases associated with synthetic cannabinoids to their local health department, the agency said.

Related News Articles

Insights and Analysis
Also in this weekly roundup of health-related news: treatment options scarce as meth deaths flare; app makes donating blood easier
Insights and Analysis
Effingham, Ill.-based St. Anthony’s Memorial Hospital addresses diabetic patients’ social risk factors; Adventist Health White Memorial Diabetes Program in Los…
Headline
Virginia hospitals and health systems provided nearly $3.3 billion in community benefit and other support in 2017, according to the latest annual report by the…
Headline
A coalition of 40 health care and public health organizations, including the AHA, today urged the Senate to quickly pass the Pandemic and All-Hazards…
Insights and Analysis
The secret to healthy, long lives lies in their social determinants. Six hospitals in a vulnerable area of Chicago pooled resources and ideas to address those…
Insights and Analysis
Also in this weekly roundup of health news: AHA president and CEO Rick Pollack speaks to HealthLeaders about the association’s year ahead; digital health…